Clinical Trial Update: Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating celecoxib for cancer prevention in patients with Barrett's esophagus (at risk fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED